# Pantoprazole on Insulin Secretion in Diabetes

> **NCT01541735** · PHASE2,PHASE3 · COMPLETED · sponsor: **Coordinación de Investigación en Salud, Mexico** · enrollment: 14 (actual)

## Conditions studied

- Type 2 Diabetes

## Interventions

- **DRUG:** Pantoprazole
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT01541735
- **Lead sponsor:** Coordinación de Investigación en Salud, Mexico
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-01
- **Primary completion:** 2013-03
- **Final completion:** 2013-05
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2014-02-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01541735

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01541735, "Pantoprazole on Insulin Secretion in Diabetes". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01541735. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*